BridgeBio Pharma
BBIO
#1405
Rank
โ‚น1.372 T
Marketcap
โ‚น7,046
Share price
-2.75%
Change (1 day)
15.46%
Change (1 year)

Earnings for BridgeBio Pharma (BBIO)

Earnings in 2026 (TTM): -โ‚น33.57 Billion

According to BridgeBio Pharma 's latest financial reports the company's current earnings are โ‚น0.94 Billion. In 2025 the company made an earning of -โ‚น51.37 Billion a decrease over its 2024 earnings that were of -โ‚น41.05 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BridgeBio Pharma from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น33.57 Billion-34.64%
2025 -โ‚น51.37 Billion25.14%
2024 -โ‚น41.05 Billion-22.56%
2023 -โ‚น53.01 Billion41.5%
2022 -โ‚น37.46 Billion-25.1%
2021 -โ‚น50.02 Billion15.11%
2020 -โ‚น43.45 Billion67.55%
2019 -โ‚น25.94 Billion67.65%
2018 -โ‚น15.47 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-โ‚น14.75 Billion-56.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น1.69 Billion-95.00%๐Ÿ‡บ๐Ÿ‡ธ USA